{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:08:27Z","timestamp":1789549707321,"version":"build-2803163510"},"reference-count":7,"publisher":"Academy of Managed Care Pharmacy","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.18553\/jmcp.2022.28.9.1046","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T22:15:56Z","timestamp":1673648156000},"page":"1046-1052","source":"Crossref","is-referenced-by-count":11,"title":["Characteristics of adverse event reporting of Xeljanz\/Xeljanz XR, Olumiant, and Rinvoq to the US Food and Drug Administration"],"prefix":"10.18553","volume":"28","author":[{"given":"Jingjing","family":"Qian","sequence":"first","affiliation":[{"name":"Department of Health Outcomes Research and Policy, Harrison College of Pharmacy, Auburn University, Alabama."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhong","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes Research and Policy, Harrison College of Pharmacy, Auburn University, Alabama."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Shannon","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes Research and Policy, Harrison College of Pharmacy, Auburn University, Alabama."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7818","reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2147\/JIR.S219586","volume":"13","author":"Harrington R","year":"2020","journal-title":"J Inflamm Res"},{"issue":"3","key":"R5","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3390\/ijms23031246","volume":"23","author":"Toth L","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"7","key":"R7","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/annrheumdis-2018-214529","volume":"78","author":"Tanaka Y","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"R8","doi-asserted-by":"crossref","first-page":"e002012","DOI":"10.1136\/rmdopen-2021-002012","volume":"8","author":"Fleischmann R","year":"2022","journal-title":"RMD Open"},{"issue":"12","key":"R11","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1080\/14740338.2021.1962846","volume":"20","author":"Singh A","year":"2021","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"R13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.clinthera.2020.12.011","volume":"43","author":"Beninger P","year":"2021","journal-title":"Clin Ther"},{"key":"R18","doi-asserted-by":"crossref","first-page":"792877","DOI":"10.3389\/fphar.2021.792877","volume":"12","author":"Song YK","year":"2021","journal-title":"Front Pharmacol"}],"container-title":["Journal of Managed Care &amp; Specialty Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T23:46:29Z","timestamp":1673653589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2022.28.9.1046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.18553\/jmcp.2022.28.9.1046"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2022.28.9.1046","relation":{},"ISSN":["2376-0540","2376-1032"],"issn-type":[{"value":"2376-0540","type":"print"},{"value":"2376-1032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}